ELIZABETH HAGAN: Open Payments
NPI 1841434388 · CULPEPER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 14 payments from 12 companies in 2025. Trend: 2023 $545 · 2024 $369 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $122 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Biogen, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $16 |
Products named: JOURNAVX, TRELEGY ELLIPTA, Kerendia, CAPLYTA, VIVITROL, Wegovy, ZURZUVAE, THINPREP 2000 PROCESSOR.
Industry payments across VA — which companies pay providers there.
